Sandrine Grossetete
Paris, 75005, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Genome-wide association study meta-analysis identifies susceptibility loci informing Ewing sarcoma etiology and potential mechanisms of risk.
Journal: medRxiv : the preprint server for health sciences
Published: February 23, 2026
The hegemonic EWSR1::ETS oncoprotein overrules core regulatory circuitry principles in Ewing sarcoma.
Journal: NPJ precision oncology
Published: May 30, 2025
Targeted long-read sequencing of the Ewing sarcoma 6p25.1 susceptibility locus identifies germline-somatic interactions with EWSR1-FLI1 binding.
Journal: American journal of human genetics
Published: September 29, 2022
Upregulation of the Mevalonate Pathway through EWSR1-FLI1/EGR2 Regulatory Axis Confers Ewing Cells Exquisite Sensitivity to Statins.
Journal: Cancers
Published: April 08, 2022
Oncogenic chimeric transcription factors drive tumor-specific transcription, processing, and translation of silent genomic regions.
Journal: Molecular cell
Published: September 15, 2021
Intra- and extra-cranial BCOR-ITD tumours are separate entities within the BCOR-rearranged family.
Journal: The journal of pathology. Clinical research
Published: June 29, 2021
Unraveling Ewing Sarcoma Tumorigenesis Originating from Patient-Derived Mesenchymal Stem Cells.
Journal: Cancer research
Published: November 18, 2020
ERG transcription factors have a splicing regulatory function involving RBFOX2 that is altered in the EWS-FLI1 oncogenic fusion.
Journal: Nucleic acids research
Published: May 27, 2020
STAG2 mutations alter CTCF-anchored loop extrusion, reduce cis-regulatory interactions and EWSR1-FLI1 activity in Ewing sarcoma.
Journal: Cancer cell
Published: December 02, 2019
Last Updated: 09/26/2026